Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Leukemia & lymphoma·2016

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Leukemia & lymphoma·2016

Relationship between response rate and median survival in patients with advanced nonsmall cell lung-cancer - comparison of onconase(r) with other anticancer agents.

International journal of oncology·2011

Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES.

International journal of oncology·2011

Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis.

Amino acids·2007

Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.

Oncology reports·2004

Loberamisal for Acute Ischemic Stroke: The LAIS Randomized Clinical Trial.

JAMA·2026

Rheumatoid Arthritis in Adults: A Review.

JAMA·2026

TFAP2B and FOXC1 are associated with biologically and clinically distinct differentiation states in triple-negative breast cancer.

Scientific reports·2026

Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).

Iranian biomedical journal·2026

Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.

Oncogene·2026

Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer.

Oncogene·2026

Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.

Lung cancer (Amsterdam, Netherlands)·2026

Use of extracorporeal membrane oxygenation (ECMO) in Spain as a method of organ preservation for transplantation.

Medicina intensiva·2026

Related Experiment Videos

Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy

Related Concept Videos

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Relationship between response rate and median survival in patients with advanced nonsmall cell lung-cancer - comparison of onconase(r) with other anticancer agents.

Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES.

Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis.

Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.

Loberamisal for Acute Ischemic Stroke: The LAIS Randomized Clinical Trial.

Rheumatoid Arthritis in Adults: A Review.

TFAP2B and FOXC1 are associated with biologically and clinically distinct differentiation states in triple-negative breast cancer.

Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).

Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.

Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer.

Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.

Use of extracorporeal membrane oxygenation (ECMO) in Spain as a method of organ preservation for transplantation.

Related Experiment Videos

Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy

Related Concept Videos

Related Articles